Skip to main content
NCBI home page
The Canadian Veterinary Journal logoLink to The Canadian Veterinary Journal
letter
. 1993 Jun;34(6):371–373.

Immunotherapy of equine cutaneous lymphosarcome using low dose cyclophosphamide and autologous tumor cells infected with vaccinea virus

Robert D Gollagher, Barry Ziola, Brian J Chelack, Deborah M Haines
PMCID: PMC1686569  PMID: 17424244

Full text

PDF
371

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer T. P., Bretscher P., Ziola B. Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity. Clin Exp Metastasis. 1990 Nov-Dec;8(6):519–532. doi: 10.1007/BF00135875. [DOI] [PubMed] [Google Scholar]
  2. Berd D., Mastrangelo M. J. Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide. Cancer Invest. 1988;6(3):337–349. doi: 10.3109/07357908809080657. [DOI] [PubMed] [Google Scholar]
  3. Campbell T. M., Studdert M. J., Ellis W. M., Paton C. M. Attempted reconstitution of a foal with primary severe combined immunodeficiency. Equine Vet J. 1983 Jul;15(3):233–237. doi: 10.1111/j.2042-3306.1983.tb01776.x. [DOI] [PubMed] [Google Scholar]
  4. Cottney J., Bruin J., Lewis A. J. Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization. Agents Actions. 1980 Sep;10(4):378–388. doi: 10.1007/BF01971444. [DOI] [PubMed] [Google Scholar]
  5. Hoon D. S., Foshag L. J., Nizze A. S., Bohman R., Morton D. L. Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide. Cancer Res. 1990 Sep 1;50(17):5358–5364. [PubMed] [Google Scholar]

Articles from The Canadian Veterinary Journal are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES